Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04KZS
|
|||
| Former ID |
DIB009453
|
|||
| Drug Name |
PRO-045
|
|||
| Synonyms |
Exon-45 skipping antisense oligonucleotide (Duchenne muscular dystrophy), Prosensa
Click to Show/Hide
|
|||
| Indication | Duchenne dystrophy [ICD-11: 8C70; ICD-10: G71.0] | Phase 1/2 | [1] | |
| Company |
Prosensa Therapeutics BV
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01826474) Phase IIb Study of PRO045 in Subjects With Duchenne Muscular Dystrophy. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.